Morgan Keegan Has Market Perform On Alliance HealthCare Services

Morgan Keegan is out with a research report on Alliance HealthCare Services AIQ and it has a Market Perform rating and a $4.75 price target on shares as it previews earnings. In a note to clients, Morgan Keegan writes, "Our adjusted EBITDA estimate is $43 million, up slightly from $42.5 million in the prior year period. We consider this a better indicator of profitability than EPS due to high amounts of noncash depreciation and amortization. Our EPS estimate of $0.00 is in line with the First Call consensus." Shares of AIQ gained 25 cents on Friday to close at $3.61.